Newsroom
November 28, 2022
The University of Texas System Board of Regents on Nov. 17 approved $2.5 million to establish the Trauma Research and Combat Casualty Care Collaborative at UT Health San Antonio in partnership with University Health’s Level 1 Trauma Center at University Hospital and the U.S. Department of Defense. The new trauma care research center will be the first and only one of its kind in the United States, according to UT System.
August 11, 2022
Four years after welcoming its first cohort of students, the Master of Science in Speech-Language Pathology program has received its five-year accreditation. “This is a five-year milestone we reached, and this is going to turn into another chapter,” said Associate Professor and Department Chair Fang-Ling Lu, PhD, CCC-SLP. “We’re going to keep improving and […]
June 27, 2022
Media contact: Steven Lee, lees22@uthscsa.edu, (210) 450-3823, or Will Sansom, sansom@uthscsa.edu, (210) 567-2579 Produced and contributed by Joel Williams and Julie Collins. SAN ANTONIO (June 27, 2022) – The first therapy to be developed specifically for post-traumatic headache significantly reduced related disability in veterans following a traumatic brain injury (TBI). It also reduced co-occurring symptoms of […]
June 15, 2022
Drug conceived at UT Health San Antonio was safe, effective in animal studies Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO, TEXAS, AND GROTON, CONN. (Wednesday, June 15, 2022) — An experimental brain injury medication conceived in laboratories at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was tested Tuesday, […]
April 20, 2022
Thanks to international collaboration, more genetic variations for Alzheimer’s disease are known today than ever before. The list of gene variants recognized for late-onset Alzheimer’s grew from one in 2009 to 40 in 2022. This month, scientists published a list of 75, some of which are considered as prime drug targets. Drug development is underway.
February 9, 2022
Treatment could aim to raise levels of a neuroprotective molecule, studies hint. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Feb. 9, 2022) — Growing evidence suggests that traumatic brain injury (TBI) is an important risk factor for developing Alzheimer’s disease and dementia. But to date, effective therapies aren’t available for preventing or treating TBI-induced […]